Table 5.

Major complications in the three intervention groups. Patients were additionally subdivided into critically ill (white space) and noncritically ill (gray space)

	Rotarex®	Lysis	Rotarex®+lysis	Total	P-value
Major bleeding	3.6% (5/138)	22.2% (4/18)	0	5.11% (9/176)	R vs L* R vs R+L ns L vs R+L*
	0	10% (1/10)	25% (2/8)	11.5% (3/26)	R vs L ns R vs R+L** L vs R+L ns
Aneurysma sp.	2.9% (4/138)	0	0	2.3% (4/176)	ns
	0	0	12.5% (1/8)*	3.8% (1/26)	ns
AV-fistula	0.7% (1/138)	0	0	0.6% (1/176)	ns
	0	0	0	0	ns
Compartment	0	0	0	0	ns
	0	0	12.5% (1/8)	3.8% (1/26)	R vs L ns R vs R+L* L vs R+L*
Hospital length stay (days)	1.4±0.9	4.6±3	4.4±1.8	–	R vs L*** R vs R+L*** L vs R+L ns
	21.7±34.4	13.3±4.5	18.3±9.36	–	ns

Notes:

^*P<0.05,

^**P<0.01, and

^***P<0.001. Data are presented as mean ± standard deviation or % (n/N).

Abbreviations: R, Rotarex^®; L, lysis; ns, nonsignificant; AV, arteriovenous.